BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN
申请人:Staehle Wolfgang
公开号:US20110230471A1
公开(公告)日:2011-09-22
Compounds of the formula (I), in which R
1
, R
2
, R
3
, R
4
, R
5
, D, Z, X, Y, m and p have the meanings indicated in Claim
1
, can and be employed for the treatment of tumours.
[DE] BENZO-NAPHTYRIDIN VERBINDUNGEN ALS INHIBITOREN VON AUTOTAXIN<br/>[EN] BENZONAPHTYRIDINE COMPOUNDS USED AS INHIBITORS OF AUTOTAXIN<br/>[FR] COMPOSÉS DE BENZONAPHTYRIDINE EN TANT QU'INHIBITEURS DE L'AUTOTAXINE
申请人:MERCK PATENT GMBH
公开号:WO2010060532A1
公开(公告)日:2010-06-03
Verbindungen der Formel (I) worin R1, R2, R3, R4, R5,D, Z, X, Y, m und p die in Anspruch 1 angegebenen Bedeutungen haben, können und zur Behandlung von Tumoren eingesetzt werden.
[EN] COMPOSITIONS AND METHODS FOR TREATING MALARIA<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT DU PALUDISME
申请人:UNIV RUTGERS
公开号:WO2021167894A1
公开(公告)日:2021-08-26
Disclosed are methods of treating malaria with tetrahydrobenzonaphtyridine carboxanilide (TBN) derivatives and related pyrrolinones and hydrolysis products thereof. These compounds are active against Plasmodium falciparum strains that are resistant to multiple drugs currently on the market. The present invention further relates to novel compounds and pharmaceutical compositions comprising such compounds.